Skip to main content
Trending storyWatching

Unravel Health raises €2.96M for at-home hormone testing

1 reports1 report sources2 days agoUpdate

Get up to speed on this story

AI Summary

London-based Unravel Health has raised €2.96 million (£2.5 million) to develop the Micro Lab, a palm-sized device it says reads multiple hormones from a saliva sample in minutes for daily at-home testing. The round was led by Conduit EIS Impact Fund and Wrightwood, with Leo Capital, Embryo Ventures, Hermesa and returning investor Zinc VC participating. It completed a first close of over €2.36 million (£2 million) on October 14 and will close with final investors in the coming weeks. The funding is to take the Micro Lab to its first early-access devices in 2027, through partners in pharmacy, digital health and clinical research.

AI-generated from reports · 2 days agoUpdate

Latest updatesOct 16 16:52
London's Unravel Health raises €2.96M for at-home hormone testing device

Report timeline

Follow the reports to understand different sides of the story.

Oct 16
  1. EU-StartupsTop Deals
    London's Unravel Health raises €2.96M for at-home hormone testing device

    London-based Unravel Health raised €2.96 million led by Conduit EIS Impact Fund and Wrightwood.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing